On July 11, CRO concept stocks witnessed another surge, with WuXi AppTec and Porton Pharmaceuticals both hitting their daily trading limits. Medicilon recorded gains exceeding 10%, while Ascletis and Pharmaron also featured prominently among the top gainers.